Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-11-09, Stock:JNJ, The news for the past five days is as follows:
2018-11-02: NEWS1: TESARO (TSRO) Q3 Earnings Beat, Revenues Miss, Shares Up.NEWS2: TESARO (TSRO) Q3 Earnings Beat, Revenues Miss, Shares Up.NEWS3: AbbVie sees hit to Humira sales from European competition.NEWS4: AbbVie's (ABBV) Q3 Earnings Beat Estimates, 2018 EPS View Up.NEWS5: AbbVie's (ABBV) Q3 Earnings Beat Estimates, 2018 EPS View Up.NEWS6: MARKETS: Now Facebook, J&J, Pfizer and Merck are dragging down the market, while Exxon and Chevron are bright spots.NEWS7: VIVUS (VVUS) Q3 Loss Narrower Than Expected, Revenues Up Y/Y.NEWS8: VIVUS (VVUS) Q3 Loss Narrower Than Expected, Revenues Up Y/Y.NEWS9: How Geron's Horrible Year Is a Great Reminder to Investors.NEWS10: How Geron's Horrible Year Is a Great Reminder to Investors.NEWS11: IWD, JPM, XOM, JNJ: ETF Inflow Alert.NEWS12: IWD, JPM, XOM, JNJ: ETF Inflow Alert.NEWS13: The Kiplinger Dividend 15: Our Favorite Dividend-Paying Stocks.NEWS14: The Kiplinger Dividend 15: Our Favorite Dividend-Paying Stocks.NEWS15: AbbVie Earnings, Revenue beat in Q3.NEWS16: How Geron&apos;s Horrible Year Is a Great Reminder to Investors.NEWS17: 5 of the Best Blue-Chip Stocks to Ride the Dow Rally.NEWS18: Geron's (GERN) Q3 Earnings Beat, Revenues Miss, Shares Down.NEWS19: Geron's (GERN) Q3 Earnings Beat, Revenues Miss, Shares Down.NEWS20: Health Care Sector Update for 11/02/2018: PACB, ILMN, EXEL, PBYI, JNJ, PFE, ABT, MRK, AMGN.NEWS21: Health Care Sector Update for 11/02/2018: PACB, ILMN, EXEL, PBYI, JNJ, PFE, ABT, MRK, AMGN.NEWS22: Geron&apos;s (GERN) Q3 Earnings Beat, Revenues Miss, Shares Down.NEWS23: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS24: Scary Markets, Frightening Stocks, and How to Keep From Panicking.
2018-11-05: NEWS1: 5 Top Stock Trades for Tuesday: Pepsi Is Strong, but Not Activision.NEWS2: Pacira (PCRX) Q3 Earnings and Revenues Surpass Estimates.NEWS3: Pacira (PCRX) Q3 Earnings and Revenues Surpass Estimates.NEWS4: Jim Cramer: The Stock Market's Machine Buyers.NEWS5: Health Care Sector Update for 11/05/2018: BTAI, FOLD, TFX, PFE, JNJ, ABT, MRK, AMGN.NEWS6: Health Care Sector Update for 11/05/2018: BTAI, FOLD, TFX, PFE, JNJ, ABT, MRK, AMGN.NEWS7: Gilead Sciences: Analysts’ Recommendations.NEWS8: The Zacks Analyst Blog Highlights: Intel, Exxon Mobil, Johnson & Johnson, JPMorgan and Microsoft.NEWS9: The Zacks Analyst Blog Highlights: Intel, Exxon Mobil, Johnson & Johnson, JPMorgan and Microsoft.NEWS10: The Zacks Analyst Blog Highlights: Intel, Exxon Mobil, Johnson & Johnson, JPMorgan and Microsoft.
2018-11-06: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Beaten-Down Pharma ETFs to Buy Post Q3 Results.NEWS3: Beaten-Down Pharma ETFs to Buy Post Q3 Results.NEWS4: Beaten-Down Pharma ETFs to Buy Post Q3 Results.NEWS5: Johnson & Johnson to Participate in the Credit Suisse 27th Annual Healthcare Conference.NEWS6: Election Day 2018: Here Are the Winners & Losers.NEWS7: Election Day 2018: Here Are the Winners & Losers.NEWS8: Health Care Sector Update for 11/06/2018: RGLS, SNY, MYL, LLY, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 11/06/2018: RGLS, SNY, MYL, LLY, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Two Studies Measure Performance of ACUVUE OASYS with Transitions Light Intelligent Technology Contact Lenses in Simulated Sunlight, Day and Night Driving Conditions.NEWS11: Democrats Hold Edge in House Battle: 5 Great Picks.NEWS12: Democrats Hold Edge in House Battle: 5 Great Picks.NEWS13: Democrats Hold Edge in House Battle: 5 Great Picks.NEWS14: 5 Top Stock Trades for Tuesday: Pepsi Is Strong, but Not Activision.NEWS15: 5 Top Stock Trades for Tuesday: Pepsi Is Strong, but Not Activision.
2018-11-07: NEWS1: Better Buy: Eli Lilly and Company vs. AbbVie Inc..NEWS2: Better Buy: Eli Lilly and Company vs. AbbVie Inc..NEWS3: Cramer on Washington gridlock: Buy fast growers.NEWS4: Cramer's advice on investing during Washington gridlock: ....NEWS5: Better Buy: Eli Lilly and Company vs. AbbVie Inc..NEWS6: Dow, Nasdaq Rally Strong As Growth Stocks Show These 5 Bullish Signs.NEWS7: Bristol-Myers, Infinity to Test Opdivo Combo for Bladder Cancer.NEWS8: Bristol-Myers, Infinity to Test Opdivo Combo for Bladder Cancer.NEWS9: Johnson & Johnson Vision Announces Health Canada has issued a Medical Device License for First-of-its-Kind Contact Lens ACUVUE OASYS with Transitions Light Intelligent Technology.NEWS10: 'We have a lot of things in common' — Trump wants to work with Democrats on infrastructure, drugs.NEWS11: Trump says he hopes to work with Democrats on infrastructure, drug pricing.NEWS12: Here&apos;s Why Arrowhead Pharmaceuticals Dropped 33.6% in October.NEWS13: The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Facebook and Twitter.NEWS14: The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Facebook and Twitter.NEWS15: Health Care Sector Update for 11/07/2018: INGN, AXDX, FOMX, JNJ, PFE, ABT, MRK, AMGN.NEWS16: Health Care Sector Update for 11/07/2018: INGN, AXDX, FOMX, JNJ, PFE, ABT, MRK, AMGN.NEWS17: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for November 08, 2018.NEWS18: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for November 08, 2018.NEWS19: 5 Top Stocks to Make the Most of a Divided Congress.NEWS20: 5 Top Stocks to Make the Most of a Divided Congress.NEWS21: The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Facebook and Twitter.NEWS22: 5 Top Stocks to Make the Most of a Divided Congress.NEWS23: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS24: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.
2018-11-08: NEWS1: A Look at Alexion Pharmaceuticals’ Operational Performance.NEWS2: How Alexion Is Positioned in November.NEWS3: Analyzing Alexion Pharmaceuticals’ Product Performance.NEWS4: Perrigo (PRGO) Beats on Q3 Earnings, Cuts View, Shares Down.NEWS5: Perrigo (PRGO) Beats on Q3 Earnings, Cuts View, Shares Down.NEWS6: AstraZeneca's (AZN) Q3 Earnings Beat, New Drugs Drive Sales.NEWS7: AstraZeneca's (AZN) Q3 Earnings Beat, New Drugs Drive Sales.NEWS8: Theravance (TBPH) Beats on Q3 Earnings, Inks Deal for Vibativ.NEWS9: Theravance (TBPH) Beats on Q3 Earnings, Inks Deal for Vibativ.NEWS10: Theravance (TBPH) Beats on Q3 Earnings, Inks Deal for Vibativ.NEWS11: Democrats Hold Edge in House Battle: 5 Great Picks (Revised).NEWS12: Democrats Hold Edge in House Battle: 5 Great Picks (Revised).NEWS13: Health Care Sector Update for 11/08/2018: PRGO, CAH, AZN, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Health Care Sector Update for 11/08/2018: PRGO, CAH, AZN, JNJ, PFE, ABT, MRK, AMGN.NEWS15: The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Lockheed Martin and Boeing.NEWS16: Allergan plc. (AGN) Ex-Dividend Date Scheduled for November 09, 2018.NEWS17: Allergan plc. (AGN) Ex-Dividend Date Scheduled for November 09, 2018.NEWS18: Merck and Johnson & Johnson Shares Show Big Buying.NEWS19: Democrats Hold Edge in House Battle: 5 Great Picks (Revised).

Answer: Rise